| Literature DB >> 30691218 |
Mingguan Yang1, Laifeng Lu2, Shuhua Li3, Jing Zhang4, Zhenjing Li5, Shufen Wu6, Qingbin Guo7, Huanhuan Liu8, Changlu Wang9.
Abstract
Aspergillus flavus is a soilborne pathogenic fungus that poses a serious public health threat due to it contamination of food with carcinogenic aflatoxins. Our previous studies have demonstrated that benzenamine displayed strong inhibitory effects on the mycelial growth of A. flavus. In this study, we systematically investigated the inhibitory effects of benzenamine on the development, aflatoxin biosynthesis, and virulence in A. flavus, as well as the underlying mechanism. The results indicated that benzenamine exhibited great capacity to combat A. flavus at a concentration of 100 µL/L, leading to significantly decreased aflatoxin accumulation and colonization capacity in maize. The transcriptional profile revealed that 3589 genes show altered mRNA levels in the A. flavus after treatment with benzenamine, including 1890 down-regulated and 1699 up-regulated genes. Most of the differentially expressed genes participated in the biosynthesis and metabolism of amino acid, purine metabolism, and protein processing in endoplasmic reticulum. Additionally, the results brought us to a suggestion that benzenamine affects the development, aflatoxin biosynthesis, and pathogenicity of A. flavus via down-regulating related genes by depressing the expression of the global regulatory factor leaA. Overall, this study indicates that benzenamine have tremendous potential to act as a fumigant against pathogenic A. flavus. Furthermore, this work offers valuable information regarding the underlying antifungal mechanism of benzenamine against A. flavus at the level of transcription, and these potential targets may be conducive in developing new strategies for preventing aflatoxin contamination.Entities:
Keywords: Aspergillus flavus; aflatoxin B1; benzenamine; fumigation; transcriptome
Mesh:
Substances:
Year: 2019 PMID: 30691218 PMCID: PMC6410012 DOI: 10.3390/toxins11020070
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Effects of benzenamine on the hyphal growth and spore germination of Aspergillus flavus. The applied concentrations of benzenamine were 25, 50, 100, 200, and 400 µL/L. Results are presented as the mean ± SD.
Figure 2Effects of 100 µL/L of benzenamine on aflatoxin production. (A) Morphological characterization of Aspergillus flavus in the absence (CG) and presence (EG) of benzenamine. (B) Aflatoxin B1 accumulation by Aspergillus flavus in the absence (CG) and presence (EG) of benzenamine. The results are presented as mean ± SD. Asterisks indicate a significant difference between groups (*** p < 0.001), N. D. denotes not detected (<0.03 ng/g).
Figure 3Effects of 100 µL/L of benzenamine on Aspergillus flavus infection in maize. (A) CG: maize inoculated with Aspergillus flavus at five days post-inoculation; EG: maize inoculated with Aspergillus flavus exposed to benzenamine for five days. (B) The production of Aspergillus flavus conidia on maize in CG and EG. Results are presented as the mean ± SD. Asterisks indicate a significant difference between groups (*** p < 0.001).
Figure 4Number of genes showed up-regulated and down-regulated expression in experimental group (EG) vs. control group (CG).
Figure 5Gene Ontology (GO) functional classification and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway enrichment of differentially expressed genes when Aspergillus flavus was treated with benzenamine. (A) Functional categories at three developmental stages based on GO enrichment analysis of differentially expressed genes (DEGs), and the asterisk means significant enrichment (* corrected p-value <0.05). (B) KEGG pathway enrichment analysis of DEGs.
Transcript abundance of genes involved in Aspergillus flavus development.
| Gene ID | Gene Name | Log2 | Function | |
|---|---|---|---|---|
| Cell wall | ||||
| TRINITY_DN6715_c0_g1 | crh11 | −3.98 | 8.95 × 10−8 | cell wall glucanase |
| TRINITY_DN10780_c1_g3 | ags1 | −2.24 | 1.53 × 10−5 | Alpha-1,3-glucan synthase |
| TRINITY_DN17727_c0_g1 | fks1 | −1.38 | 8.42 × 10−3 | beta-1,3 -glucan synthase |
| TRINITY_DN9747_c0_g1 | rho2 | 1.42 | 2.71 × 10−4 | GTP-binding protein |
| TRINITY_DN9087_c0_g1 | rho4 | 1.31 | 5.24 × 10−3 | GTP-binding protein |
| TRINITY_DN11443_c2_g2 | cfmA | −1.51 | 3.20 × 10−4 | GPI-anchored CFEM domain protein A |
| TRINITY_DN11909_c4_g1 | afuA | −1.75 | 2.47 × 10−3 | GPI-anchored membrane protein |
| TRINITY_DN9375_c0_g1 | chs6 | −1.02 | 1.65 × 10−3 | Chitin synthase |
| TRINITY_DN10195_c0_g1 | chs8 | −1.31 | 1.13 × 10−3 | Chitin synthase |
| Cell membrane | ||||
| TRINITY_DN8232_c0_g1 | erg3 | 3.58 | 1.91 × 10−2 | C-5 sterol desaturase |
| TRINITY_DN10457_c0_g1 | erg4 | −2.87 | 8.85 × 10−6 | C6 transcription factor |
| TRINITY_DN7343_c0_g1 | erg5 | −1.80 | 5.19 × 10−3 | Cytochrome P450 |
| TRINITY_DN6009_c0_g1 | erg6 | −1.23 | 4.12 × 10−2 | 24-C-methyltransferase |
| TRINITY_DN9690_c0_g1 | erg7 | −6.36 | 6.64 × 10−21 | Lanosterol synthase |
| TRINITY_DN11958_c0_g2 | erg13 | −1.34 | 2.89 × 10−2 | Hydroxymethylglutaryl-CoA synthase |
| TRINITY_DN10380_c0_g1 | erg25 | −1.64 | 1.37 × 10−2 | Methylsterol monooxygenase |
| TRINITY_DN15242_c0_g1 | erg26 | −1.59 | 1.48 × 10−3 | Sterol-4-alpha-carboxylate 3-dehydrogenase |
| Conidia | ||||
| TRINITY_DN11281_c0_g1 | brlA | −1.27 | 8.69 × 10−4 | C2H2 type master regulator of conidiophore development |
| TRINITY_DN11770_c0_g1 | wetA | −3.99 | 1.85 × 10−21 | developmental regulatory protein |
| TRINITY_DN9659_c0_g1 | abaA | −3.17 | 1.23 × 10−12 | Conidiophore development regulator |
| TRINITY_DN11518_c0_g4 | rodA | −9.10 | 6.30 × 10−19 | Conidial hydrophobin |
| TRINITY_DN15172_c0_g1 | rodB | −6.94 | 4.97 × 10−23 | Conidial hydrophobin |
| TRINITY_DN11879_c4_g1 | stuA | −1.54 | 7.43 × 10−6 | Cell pattern formation-associated protein |
| Transcription regulator | ||||
| TRINITY_DN9345_c0_g1 | laeA | −1.82 | 5.63 × 10−5 | Secondary metabolism regulator |
| TRINITY_DN11910_c4_g1 | veA | 1.42 | 2.68 × 10−3 | Developmental and secondary metabolism regulator |
| TRINITY_DN8021_c0_g1 | fig1 | −2.59 | 4.64 × 10−3 | Ca2+ regulator and membrane fusion protein |
| TRINITY_DN10388_c0_g1 | sebA | −2.44 | 2.36 × 10−4 | C2H2 finger domain transcription factor |
| TRINITY_DN12068_c7_g5 | mtfA | 1.06 | 2.65 × 10−2 | C2H2 finger domain transcription factor |
| TRINITY_DN12136_c0_g2 | hir3 | −1.57 | 1.24 × 10−3 | Histone transcription regulator |
| Developmental signal | ||||
| TRINITY_DN7900_c0_g1 | fluG | −2.25 | 3.28 × 10−5 | Extracellular developmental signal biosynthesis protein |
| Apoptosis | ||||
| TRINITY_DN12180_c5_g1 | cycA | 2.33 | 5.30 × 10−5 | Cytochrome c |
| G-protein | ||||
| TRINITY_DN10123_c0_g1 | gblP | −1.90 | 1.37 × 10−6 | Nucleotide-binding protein subunit beta-like protein |
| TRINITY_DN9739_c0_g1 | gna12 | −2.16 | 2.48 × 10−6 | G-protein alpha subunit |
(*): CG, control group; EG, experimental group. Log2 (EG/CG) ≥1 indicate up-regulated expression and Log2 (EG/CG) ≤−1 indicate down-regulated expression.
Transcript abundance of genes that are involved in aflatoxin biosynthesis.
| Gene ID | Gene Name | Log2 | Function | |
|---|---|---|---|---|
| Aflatoxin biosynthesis | ||||
| TRINITY_DN9945_c0_g1 | aflA | −3.42 | 5.80 × 10−10 | Fatty acid synthase alpha subunit |
| TRINITY_DN6952_c0_g1 | aflB | −3.32 | 4.61 × 10−2 | Fatty acid synthase subunit beta |
| TRINITY_DN61_c0_g1 | aflD | −4.96 | 2.64 × 10−8 | Norsolorinic acid ketoreductase |
| TRINITY_DN12173_c2_g2 | aflF | −1.65 | 4.36 × 10−2 | Norsolorinic acid ketoreductase |
| TRINITY_DN10698_c0_g2 | aflO | −1.83 | 5.63 × 10−3 | |
| TRINITY_DN10938_c0_g1 | aflQ | −1.49 | 2.16 × 10−4 | Oxidoreductase |
| TRINITY_DN10167_c0_g1 | aflR | −1.86 | 1.68 × 10−2 | Aflatoxin biosynthesis regulatory protein |
| TRINITY_DN9418_c0_g1 | aflT | −2.72 | 4.27 × 10−2 | Transmembrane protein |
| TRINITY_DN399_c0_g1 | aflU | −3.24 | 2.31 × 10−8 | P450 monooxygenase |
| TRINITY_DN10373_c0_g1 | aflW | −1.60 | 1.37 × 10−2 | FAD-binding monooxygenase |
| Carbon metabolism | ||||
| TRINITY_DN7925_c1_g1 | creA | −1.14 | 9.62 × 10−5 | DNA-binding protein |
| TRINITY_DN10031_c0_g1 | mexAM | 1.55 | 1.84 × 10−2 | Oxidoreductase |
| TRINITY_DN10394_c0_g1 | pot1 | 1.90 | 1.45 × 10−6 | Acetyl-CoA C-acyltransferase |
| TRINITY_DN11110_c0_g1 | rntA | 1.88 | 5.21 × 10−6 | Guanyl-specific ribonuclease |
| TRINITY_DN11497_c0_g1 | ppoA | −1.83 | 7.67 × 10−6 | Linoleate 8R-dioxygenase like protein |
| TRINITY_DN12116_c3_g3 | ppoC | −2.79 | 9.25 × 10−4 | Fatty acid oxygenase |
| Nitrogen metabolism | ||||
| TRINITY_DN5952_c0_g1 | nmrAL1 | −1.60 | 2.14 × 10−4 | NmrA-like family domain-containing protein 1 |
| TRINITY_DN11972_c8_g2 | gdh-1 | −2.42 | 1.52 × 10−9 | Specific glutamate dehydrogenase |
| TRINITY_DN11667_c1_g3 | glt1 | −2.40 | 4.57 × 10−5 | Putative glutamate synthase |
| TRINITY_DN11707_c0_g1 | niiA | −1.73 | 4.23 × 10−8 | Nitrite reductase |
| TRINITY_DN10046_c0_g1 | nirA | −1.93 | 2.28 × 10−4 | Nitrogen assimilation transcription factor |
| TRINITY_DN13321_c0_g1 | ddc | 1.36 | 1.02 × 10−2 | Aromatic-L-amino-acid decarboxylase |
| TRINITY_DN9125_c0_g1 | aat2 | −3.66 | 1.66 × 10−2 | Aspartate aminotransferase |
| TRINITY_DN19445_c0_g1 | melO | −3.40 | 8.11 × 10−8 | Tyrosinase |
| TRINITY_DN10664_c0_g1 | orsC | −1.06 | 4.78 × 10−2 | Tyrosinase-like protein |
| TRINITY_DN11859_c0_g1 | gad1 | −4.38 | 1.27 × 10−27 | Glutamate decarboxylase |
| TRINITY_DN11916_c1_g2 | gfa1 | −1.46 | 2.29 × 10−4 | Glutamine--fructose-6-phosphate aminotransferase |
| TRINITY_DN12169_c4_g1 | sch9 | 1.86 | 2.72 × 10−4 | Serine/threonine-protein kinase |
| Purine metabolism | ||||
| TRINITY_DN12187_c1_g2 | ade17 | −1.58 | 6.35 × 10−5 | Bifunctional purine biosynthesis protein |
| TRINITY_DN8936_c0_g1 | uaY | −3.71 | 2.76 × 10−4 | Positive regulator of purine utilization |
| TRINITY_DN9209_c0_g1 | uapC | −3.11 | 1.58 × 10−9 | Purine permease |
| TRINITY_DN9614_c0_g1 | fcy2 | −2.36 | 3.47 × 10−4 | Purine-cytosine permease |
| TRINITY_DN10376_c0_g2 | pol12 | −2.28 | 3.34 × 10−2 | DNA polymerase alpha subunit B |
| TRINITY_DN8807_c0_g1 | hxA | −1.16 | 2.02 × 10−3 | Xanthine dehydrogenase |
| cAMP signaling pathway | ||||
| TRINITY_DN10852_c0_g2 | ATP12A | −2.10 | 8.03 × 10−3 | ATPase alpha 1 subunit |
| TRINITY_DN11913_c3_g2 | pld1 | −1.55 | 8.45 × 10−5 | Phospholipase D1 |
| TRINITY_DN11065_c0_g2 | pka-C3 | −1.02 | 1.11 × 10−2 | cAMP-dependent protein kinase |
(*): CG, control group; EG, experimental group. Log2 (EG/CG) ≥ 1 indicate up-regulated expression and Log2 (EG/CG) ≤ −1 indicate down-regulated expression.
Transcript abundance of genes that are involved in virulence of Aspergillus flavus.
| Gene ID | Gene Name | Log2 | Function | |
|---|---|---|---|---|
| Hydrolase | ||||
| TRINITY_DN11687_c2_g1 | mal1 | −3.39 | 6.39 × 10−10 | Alpha-glucosidase |
| TRINITY_DN18434_c0_g1 | mal2 | −2.86 | 2.02 × 10−3 | Alpha-glucosidase |
| TRINITY_DN9284_c0_g1 | agdC | −2.16 | 5.88 × 10−6 | Alpha -glucosidase |
| TRINITY_DN4002_c0_g1 | lip | −3.41 | 2.15 × 10−3 | Lipase |
| TRINITY_DN11096_c0_g3 | NPII | −7.81 | 2.84 × 10−61 | Neutral protease |
| TRINITY_DN10289_c0_g1 | ctf1B | −2.77 | 2.89 × 10−2 | Cutinase transcription factor 1 beta |
| TRINITY_DN11791_c0_g4 | ctf1A | −1.59 | 4.29 × 10−2 | Cutinase transcription factor 1 alpha |
| TRINITY_DN8062_c0_g1 | abfA | −2.71 | 2.69 × 10−3 | Alpha-L-arabinofuranosidase A |
| TRINITY_DN12177_c2_g1 | dvrA | 1.03 | 1.97 × 10−2 | C2H2 finger domain transcription factor |
(*): CG, control group; EG, experimental group. Log2 (EG/CG) ≥1 indicate up-regulated expression and Log2 (EG/CG) ≤−1 indicate down-regulated expression.
Figure 6Quantitative real-time PCR validation of aflatoxin biosynthesis genes and laeA after treatment with benzenamine. CG, control group; EG, experimental group. Results are presented as mean ± SD. Log2 (EG/CG) ≤ −1 indicates downregulated expression.
Figure 7A schematic diagram for the proposed mechanism of benzenamine against Aspergillus flavus.